Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
Price Target
Average
203.42%
Revenue Forecast
Estimate
68.51%
EBIT
Estimate
25.26%
Net Income
Estimate
2.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AnaptysBio, Inc.
Wall Street analysts predict an average 1-year price target for ANAB of $47 , with forecasts ranging from
a
low of
$19 to a high of $90 .
ANAB Lowest Price Target
Wall Street Target
19 USD
22.66%
ANAB Average Price Target
Wall Street Target
47 USD
203.42%
ANAB Highest Price Target
Wall Street Target
90 USD
481.02%
REVENUE FORECAST
Revenue Forecast Chart ANAB
EBIT FORECAST
EBIT Forecast Chart ANAB
NET INCOME FORECAST
Net Income Chart ANAB